<DOC>
	<DOC>NCT01979861</DOC>
	<brief_summary>The purpose of this study is to determine if the AEGEA Vapor System for endometrial ablation is safe and effective for reducing menstrual blood loss in women with excessive uterine bleeding (menorrhagia)</brief_summary>
	<brief_title>Safety &amp; Effectiveness Study of AEGEA Vapor System to Treat Excessive Uterine Bleeding</brief_title>
	<detailed_description>This is a single-arm, multi-center study with three years of follow-up.</detailed_description>
	<mesh_term>Menorrhagia</mesh_term>
	<mesh_term>Uterine Hemorrhage</mesh_term>
	<criteria>Female subject from (and including) age 30 to 50 years Selfreported history of heavy menstrual bleeding in at least 3 of the last 6 months Predictable cyclic menstrual cycles over past 6 months Excessive uterine bleeding Premenopausal at enrollment Normal PAP Normal endometrial biopsy Willing to use reliable contraception Not currently taking hormonal medication Agree to use sponsor provided catamenial product (sanitary pads/tampons) Pregnant Desires future childbearing Presence of an IUD Previous endometrial ablation procedure Evidence of STI Evidence of PID Active infection of genitals, vagina, cervix, uterus or urinary tract Active endometritis Active bacteremia, sepsis or other active systemic infection Gynecologic malignancy Endometrial hyperplasia Known clotting defects or bleeding disorders On anticoagulant therapy Hemoglobin &lt;8gm/dl Prior uterine surgery Currently on medication that could thin myometrial muscle Severe dysmenorrhea, secondary to adenomyosis Abnormal uterine cavity Hydrosalpinx Uterine length &lt;6cm or &gt;12cm Currently in other clinical trial</criteria>
	<gender>Female</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Endometrial ablation with vapor</keyword>
</DOC>